Navigation Links
bioLytical's INSTI HIV Assay Receives FDA Approval for HIV-2
Date:2/24/2015

RICHMOND, BC, Feb. 24, 2015 /PRNewswire/ - bioLytical Laboratories Inc., a leading manufacturer of point-of-care rapid diagnostic tests, announced today that it has received U.S. Food and Drug Administration (FDA) approval of its INSTI HIV Antibody Test for use in detecting antibodies to HIV type 2 (HIV-2). With this approval, the INSTI HIV-1/2 Antibody Test is available for use in detecting HIV-1 and HIV-2 antibodies in as little as 60 seconds.

(Photo: http://photos.prnewswire.com/prnh/20150224/177407)

Centers for Disease Control and Prevention (CDC) estimates that over 1.2 million persons aged 13 years and older are living with HIV infection in the United States, including over 168,300 (14%) who are unaware of their infection.1 With the ability to expand into more public health bodies and hospital markets, bioLytical will be able to better serve its community through more readily available HIV testing.

The Company is excited to add the HIV-2 claim to its already impressive regulatory approval credentials, including those from Health Canada and the European Union, the World Health Organization (Prequalification) and the U.S. FDA.  INSTI's FDA approval also includes a "CLIA" waiver which allows the test to be administered outside of a laboratory setting by anyone who has been trained in its use - an important consideration in global 'seek and treat' testing initiatives.  Providing HIV testing services in non-clinical venues facilitates access for individuals who may not access these services through other health care providers, those who may be testing for the first time, or those at highest risk of acquiring HIV who would benefit from repeated testing.

Mr. Robert Mackie, Executive Chairman of bioLytical Laboratories, is proud of the many accomplishments the bioLytical team has achieved as the Company surpasses yet another major milestone.  "We are expanding our sales force in multiple U.S. markets to support our revenue growth model and to continue to provide best in class service to our customers.  The FDA approved and "CLIA" waived INSTI HIV-1/2 test will allow bioLytical to further successfully penetrate the U.S. market to increase market share."

"INSTI was developed for the detection of antibodies to both HIV types and so the FDA approved HIV-2 claim will allow bioLytical to expand its markets further in the United States as some health departments require it for their testing programs.  We are thrilled to have obtained the HIV-2 designation," said Rick Galli, Chief Technical Officer of bioLytical Laboratories.

About bioLytical Laboratories

bioLytical Laboratories is a privately owned Canadian company engaged in the research, development and commercialization of rapid, point-of-care in vitro medical diagnostics using its proprietary INSTI™ technology platform.  Today, the company markets and sells its INSTI HIV test and has a world-wide footprint of regulatory approvals including U.S. FDA approval, Health Canada approval and CE mark from European regulators.  Their product provides a highly accurate HIV test result in as little as 60 seconds translating into a compelling value proposition for patients, healthcare professionals and public health organizations.  For more information on bioLytical Laboratories, please visit www.biolytical.com.


'/>"/>
SOURCE bioLytical Laboratories
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Professor of Art from Northern Virginia Community College Lectures at Cajal Institute
2. Lupus Research Institute Requests Strengthened NIH Funding for Biomedical Research in Debilitating Diseases like Lupus
3. The BioVoyage Institute Now Offering Hands-On Training Programs For Biotechnology Products & Applications
4. Philanthropist John Moores Gives $2 Million to The Scripps Research Institute to Develop River Blindness Field Test
5. The BioVoyage Institute is seeking the help of corporations, organizations, institutions, communities and individuals to help with bioscience and biotechnology education
6. Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines
7. Regenerative Medicine Company, Eqalix, Announces Grant from Nanotechnology Institute in Philadelphia, Pennsylvania
8. CellHealth Institute Launches with Support from Influential Investors
9. California Healthcare Institute Appoints Associate Director, Federal Government Relations and Programs
10. Blanchette Rockefeller Neurosciences Institute Partners with Neurotrope BioScience to Advance New Alzheimers Disease Discoveries
11. Venter Institute-Led Team Recovers and Sequences Genome of Periodontal Pathogen from Biofilm in Hospital Sink using Single-Cell Genomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2018)... , ... August 09, 2018 , ... ... architectural, engineering, and construction (AEC) experts with building owners and managers for a ... fourth-annual Create + Construct symposium comes to Boston for the first time on ...
(Date:7/31/2018)... ... 2018 , ... ZeptoMetrix™ Corporation (ZMC) announced today ... CE/IVD product inventory. , “We are pleased today to introduce two Group B ... committed to fully support and provide our diagnostics industry with as many precise ...
(Date:7/25/2018)... LAKE GENEVA, Wis. (PRWEB) , ... July 25, ... ... the impact of a biofield energy treated proprietary nutraceutical to combat inflammation and ... inflammation, as well as, immune function response. The following data was reported:, ...
(Date:7/24/2018)... OMAHA, Neb. (PRWEB) , ... July 23, 2018 ... ... the impact of a biofield energy treated nutraceutical to increase immunity and improve ... well as, immune function response assessed in the preclinical research were significantly reduced. ...
Breaking Biology Technology:
(Date:8/7/2018)... ... August 06, 2018 , ... Passersby can’t ... at Southern Illinois University Edwardsville’s University Park. SIUE students are working the “Feedstock ... sorghum. These three feedstocks represent conventional biofuels production, advanced biofuels production and cellulosic ...
(Date:8/7/2018)... SOUTH JORDAN, Utah (PRWEB) , ... August 07, 2018 , ... ... collaboration solutions, announced today their new CT Cloud Voice and SIP solutions. CT ... a scalable and secure, quality voice solution that is far superior to traditional PBX ...
(Date:8/2/2018)... ... August 02, 2018 , ... RxS ... and biotech companies, today announced that Mark Jara, principal of the organization, has ... the life sciences industry. Individuals named to PharmaVOICE 100 are leaders who drive ...
Breaking Biology News(10 mins):